Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta
February 7th, 2018
9.1K views
This article demonstrates a murine model to study the development of myointimal hyperplasia (MH) after aortic balloon injury.
Overview
This article demonstrates a murine model to study the development of myointimal hyperplasia (MH) after aortic balloon injury. This model system can help answer key questions about the factors contributing to MH development.
Key Study Components
Area of Science
- Neuroscience
- Cardiovascular Biology
- Pathophysiology
Background
- Myointimal hyperplasia is a significant pathological process following vascular injury.
- Understanding its development can lead to better therapeutic strategies.
- Transgenic mouse models provide insights into the disease mechanisms.
- The disease progresses rapidly in this model, allowing for timely observations.
Purpose of Study
- To investigate the development of myointimal hyperplasia after aortic balloon injury.
- To identify contributing factors to the disease.
- To enhance understanding of the pathomechanism of myointimal hyperplasia.
Methods Used
- Use of a murine model for studying vascular injury.
- Aortic balloon injury technique to induce myointimal hyperplasia.
- Observation of disease progression over weeks.
- Analysis of transgenic mice to explore genetic factors.
Main Results
- Rapid progression of myointimal hyperplasia observed in the model.
- Identification of key factors influencing the development of the disease.
- Insights into the pathomechanism of myointimal hyperplasia.
- Potential for future therapeutic interventions based on findings.
Conclusions
- The murine model is effective for studying myointimal hyperplasia.
- Findings contribute to the understanding of vascular injury responses.
- Future research can build on this model to develop treatments.
Frequently Asked Questions
What is myointimal hyperplasia?
Myointimal hyperplasia is the proliferation of smooth muscle cells in the intima of blood vessels, often following injury.
Why use a murine model?
Murine models allow for controlled studies of disease mechanisms and rapid observation of disease progression.
What is the significance of aortic balloon injury?
Aortic balloon injury is a common method to induce vascular injury and study subsequent pathological changes.
How does this study contribute to cardiovascular research?
It provides insights into the mechanisms of myointimal hyperplasia, which is crucial for developing therapeutic strategies.
What are transgenic mice?
Transgenic mice are genetically modified to express or silence specific genes, allowing researchers to study their effects on disease.
What are the potential applications of this research?
The findings could lead to new treatments for vascular diseases associated with myointimal hyperplasia.
Executive Industry Relevance
This murine balloon denudation model enables reproducible induction of myointimal hyperplasia in the abdominal aorta, providing a disease-relevant system for evaluating therapeutic agents targeting vascular stenosis. The model supports mechanistic de-risking by allowing assessment of gene-specific contributions to pathological remodeling using knockout strains. Its rapid progression and compatibility with expensive compounds facilitate early-stage target validation and predictive confidence in preclinical programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogate therapeutic hypotheses by assessing the impact of specific genes on myointimal hyperplasia development using knockout-mouse strains.
- Operational Value: Enable biological de-risking through reproducible vessel injury that mimics clinical angioplasty settings.
Screening & Assay Development
- Scientific Value: Prepare validated biological systems for downstream evaluation of expensive experimental agents in an economical fashion.
- Operational Value: Establish a standardized, quick-to-perform model that supports assay readiness and scalability for compound screening.
Translational & Preclinical Research
- Scientific Value: Maintain disease relevance through pathobiological and physiological changes comparable to large animal models and clinical settings.
- Operational Value: Support translational continuity from discovery through preclinical evaluation of vascular injury responses.
Pipeline & Workflow Integration
The model fits within the discovery continuum from target validation to preclinical research, enabling hypothesis testing and pathway clarification in vascular biology.
- Discovery Biology: Support hypothesis testing and pathway clarification by inducing controlled aortic injury to study myointimal hyperplasia mechanisms.
- Screening: Enable assay readiness and reproducible quantitative outcomes for evaluating therapeutic agents on lesion development.
- Analytics: Facilitate measurements of lesion area, cellular composition, and extracellular matrix deposition via histological staining to compare experimental conditions.
- Translational Research: Connect to preclinical continuity through disease-relevant remodeling that mirrors human vascular pathology.
- Enterprise Reuse: Frame the model as a reusable platform for iterative target validation across multiple genetic backgrounds and therapeutic candidates.
Operational & Enterprise Impact
- Scientific Value: Provide predictive confidence in target validation by reducing mechanistic ambiguity in vascular injury responses.
- Operational Value: Offer standardization, reproducibility, and scalability for high-throughput evaluation of genetic and pharmacological modifiers.
- Strategic Value: Improve go/no-go decisions by enabling early de-risking of targets involved in restenosis pathways.
- Portfolio Impact: Support risk-adjusted prioritization of vascular therapeutic candidates based on mechanistic insights from the model.
Implementation Considerations
- Required expertise in microsurgical techniques, vascular anatomy, and postoperative care in mice.
- Need for specialized instrumentation including balloon catheters, microsutures, heparinized solutions, and histological analysis tools.
- Standardization across laboratories requires consistent catheter preparation, inflation pressures, and incision techniques to ensure reproducible injury.
- Adaptation considerations include varying mouse strains, ages, and genetic backgrounds to model different pathophysiological contexts.
- Practical limitations include technical variability in catheter placement and the need for skilled personnel to achieve consistent denudation without vessel rupture.
Biopharma FAQs
Why does balloon denudation matter for target validation?
Balloon denudation creates a reproducible vascular injury model that enables assessment of gene-specific contributions to myointimal hyperplasia using knockout-mouse strains, supporting mechanistic de-risking in target validation programs.
How does isolating the independent variable of vascular injury fit the discovery pipeline?
By standardizing aortic balloon injury as the independent variable, researchers can isolate the effects of genetic or pharmacological interventions on lesion development, enabling clear hypothesis testing in early discovery.
What quantitative dependent variable measurements enable target assessment?
Histological staining with Masson's trichrome and immunostaining for SM22 allow quantification of myointimal lesion area, smooth muscle cell content, and extracellular matrix deposition, providing measurable endpoints for evaluating therapeutic or genetic effects.
Why do replication requirements matter for cross-functional collaboration?
The model's reproducibility—demonstrated by low mortality and consistent lesion formation across surgeries—ensures reliable data sharing between discovery, preclinical, and translational teams, supporting aligned decision-making.
What statistical analysis capabilities are required before implementation?
Implementation requires capability to analyze lesion morphometry, cellular positivity, and matrix deposition across experimental groups, enabling statistical comparison of intervention effects on myointimal hyperplasia progression.
